Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study

OBJECTIVE: We hypothesized that florbetapir, a Food and Drug Administration–approved PET tracer, could distinguish cerebral amyloid angiopathy (CAA)–related intracerebral hemorrhage (ICH) from hypertensive ICH (HTN-ICH). METHODS: We prospectively enrolled survivors of primary ICH related to probable...

Full description

Saved in:
Bibliographic Details
Published in:Neurology
Main Authors: Gurol, M. Edip, Becker, J. Alex, Fotiadis, Panagiotis, Riley, Grace, Schwab, Kristin, Johnson, Keith A., Greenberg, Steven M.
Format: Artigo
Language:Inglês
Published: Lippincott Williams & Wilkins 2016
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5109947/
https://ncbi.nlm.nih.gov/pubmed/27605173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003197
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items